Precigen, Inc. Common Stock
Here’s whether Precigen, Inc. Common Stock (PGEN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.47% over 10 days); RSI 45 — healthy momentum range; strong 1-year return of +237.5%; 3-month momentum positive (+30.8%). Concerns: declining volume on rally — weak conviction (0.65x 30d avg). Currently 10.6% off its 52-week high. Score: +6/7.
PGEN is in a confirmed uptrend, trading above both its 50-day ($4.80) and 200-day ($4.22) moving averages. An RSI of 44.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +237.5% compares to +16.5% for SPY (beat the market by 221.0%).